These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25814297)

  • 1. Dual-energy contrast-enhanced spectral mammography (CESM).
    Daniaux M; De Zordo T; Santner W; Amort B; Koppelstätter F; Jaschke W; Dromain C; Oberaigner W; Hubalek M; Marth C
    Arch Gynecol Obstet; 2015 Oct; 292(4):739-47. PubMed ID: 25814297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions.
    Xing D; Lv Y; Sun B; Xie H; Dong J; Hao C; Chen Q; Chi X
    J Comput Assist Tomogr; 2019; 43(2):245-251. PubMed ID: 30531546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrast-enhanced spectral mammography: Does mammography provide additional clinical benefits or can some radiation exposure be avoided?
    Fallenberg EM; Dromain C; Diekmann F; Renz DM; Amer H; Ingold-Heppner B; Neumann AU; Winzer KJ; Bick U; Hamm B; Engelken F
    Breast Cancer Res Treat; 2014 Jul; 146(2):371-81. PubMed ID: 24986697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of contrast-enhanced spectral mammography for intramammary cancer staging: preliminary results.
    Blum KS; Rubbert C; Mathys B; Antoch G; Mohrmann S; Obenauer S
    Acad Radiol; 2014 Nov; 21(11):1363-9. PubMed ID: 25127846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Radiation Dose With CESM Compared With 2D FFDM and 3D Tomosynthesis Mammography.
    James JR; Pavlicek W; Hanson JA; Boltz TF; Patel BK
    AJR Am J Roentgenol; 2017 Feb; 208(2):362-372. PubMed ID: 28112559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.
    Fallenberg EM; Dromain C; Diekmann F; Engelken F; Krohn M; Singh JM; Ingold-Heppner B; Winzer KJ; Bick U; Renz DM
    Eur Radiol; 2014 Jan; 24(1):256-64. PubMed ID: 24048724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiomammography: A review of current evidences.
    Dromain C; Vietti-Violi N; Meuwly JY
    Diagn Interv Imaging; 2019 Oct; 100(10):593-605. PubMed ID: 30962168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced spectral mammography (CESM) and contrast enhanced MRI (CEMRI): Patient preferences and tolerance.
    Hobbs MM; Taylor DB; Buzynski S; Peake RE
    J Med Imaging Radiat Oncol; 2015 Jun; 59(3):300-5. PubMed ID: 25900704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced Spectral Mammography: Technique, Indications, and Clinical Applications.
    Bhimani C; Matta D; Roth RG; Liao L; Tinney E; Brill K; Germaine P
    Acad Radiol; 2017 Jan; 24(1):84-88. PubMed ID: 27773458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic performance of contrast-enhanced dual-energy spectral mammography (CESM): a retrospective study involving 644 breast lesions.
    Travieso-Aja MDM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Vega Benítez V; Pérez-Luzardo O
    Radiol Med; 2019 Oct; 124(10):1006-1017. PubMed ID: 31250270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
    Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
    Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Mammography, Contrast-Enhanced Spectral Mammography and Ultrasonography in a Group of 116 patients.
    Luczyńska E; Heinze S; Adamczyk A; Rys J; Mitus JW; Hendrick E
    Anticancer Res; 2016 Aug; 36(8):4359-66. PubMed ID: 27466557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation Between Enhancement Intensity in Contrast Enhancement Spectral Mammography and Types of Kinetic Curves in Magnetic Resonance Imaging.
    Rudnicki W; Heinze S; Piegza T; Pawlak M; Kojs Z; Łuczyńska E
    Med Sci Monit; 2020 Mar; 26():e920742. PubMed ID: 32173716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrast-enhanced spectral mammography in patients with MRI contraindications.
    Richter V; Hatterman V; Preibsch H; Bahrs SD; Hahn M; Nikolaou K; Wiesinger B
    Acta Radiol; 2018 Jul; 59(7):798-805. PubMed ID: 29058963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced spectral mammography as work-up tool in patients recalled from breast cancer screening has low risks and might hold clinical benefits.
    Houben IPL; Van de Voorde P; Jeukens CRLPN; Wildberger JE; Kooreman LF; Smidt ML; Lobbes MBI
    Eur J Radiol; 2017 Sep; 94():31-37. PubMed ID: 28941757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
    Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
    Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deep learning approach for virtual contrast enhancement in Contrast Enhanced Spectral Mammography.
    Rofena A; Guarrasi V; Sarli M; Piccolo CL; Sammarra M; Zobel BB; Soda P
    Comput Med Imaging Graph; 2024 Sep; 116():102398. PubMed ID: 38810487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.